Related Experiment Video
Updated: Aug 1, 2025

06:38
Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
28.4K
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Qindong Zhang1,2, Mouldy Sioud1
1Division of Cancer Medicine, Department of Cancer Immunology, Oslo University Hospital, University of Oslo, Ullernchausseen 70, 0379 Oslo, Norway.
International Journal of Molecular Sciences
|April 28, 2023
Summary
Tumor-associated macrophages (TAMs) play a dual role in cancer. This review details M2 macrophage subsets, their pro-tumor functions, and strategies to target them for effective cancer therapy.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- The tumor microenvironment (TME) critically influences cancer progression and metastasis.
- Macrophages are abundant innate immune cells within the TME, exhibiting M1/M2 polarization.
- M2 macrophages promote tumor growth, angiogenesis, metastasis, and therapy resistance.
Purpose of the Study:
- To review the distinct subsets of M2 macrophages (M2a, M2b, M2c, M2d).
- To elucidate the specific functions and implications of each M2 subset in various cancers.
- To highlight emerging strategies for targeting TAMs in cancer treatment.
Main Methods:
- Literature review of studies on macrophage polarization in the TME.
- Analysis of phenotypic and functional differences among M2 macrophage subsets.
- Synthesis of current research on therapeutic strategies targeting TAMs.
Main Results:
- M2 macrophages, unlike M1, exhibit pro-tumoral functions.
- Distinct stimuli induce specific M2 subsets (M2a-M2d) with varying roles.
- TAMs represent a promising target for novel cancer therapies.
Conclusions:
- Understanding M2 macrophage heterogeneity is crucial for cancer research.
- Targeting specific M2 subsets offers potential for developing more effective cancer treatments.
- Harnessing TAMs presents a viable strategy for improving cancer therapy outcomes.

